APOMORPHINE TOLERANCE IN PARKINSONS-DISEASE - LACK OF A DOSE-EFFECT

Citation
St. Gancher et al., APOMORPHINE TOLERANCE IN PARKINSONS-DISEASE - LACK OF A DOSE-EFFECT, Clinical neuropharmacology, 19(1), 1996, pp. 59-64
Citations number
18
Categorie Soggetti
Clinical Neurology","Pharmacology & Pharmacy
Journal title
ISSN journal
03625664
Volume
19
Issue
1
Year of publication
1996
Pages
59 - 64
Database
ISI
SICI code
0362-5664(1996)19:1<59:ATIP-L>2.0.ZU;2-H
Abstract
The development of tolerance to dopaminergic drugs may be important in the long-term therapy of Parkinson's disease. In this study, we sough t to determine whether tolerance developed during infusions of apomorp hine and if there was evidence of any dose dependency. Eight patients with Parkinson's disease received 4- to 6-h infusions of apomorphine a t low, medium, and high rates on consecutive days. Before and after ea ch infusion, test boluses of apomorphine were administered to measure sensitivity to the drug. The duration of motor effects after the posti nfusion boluses were reduced in comparison to those of the preinfusion boluses, indicating that tolerance developed during the infusions. Th e infusion rate did not affect the responses to the postinfusion test boluses. Our observations indicate that tolerance develops to the anti parkinsonian effect of apomorphine after several hours of its constant infusion, but is not influenced by the dose of drug administered.